High Net Worth Advisory Group’s Gilead Sciences GILD Stock Holding History

High Net Worth Advisory Group’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$478K	Hold	3,786	–	–	0.1%	155
2026 Q1	$528K	Sell	3,786 -150	-4%	-$21K	0.12%	140
2025 Q4	$483K	Hold	3,936	–	–	0.11%	145
2025 Q3	$437K	Buy	3,936 +42	+1%	+$4.77K	0.11%	147
2025 Q2	$432K	Hold	3,894	–	–	0.11%	141
2025 Q1	$436K	Hold	3,894	–	–	0.12%	137
2024 Q4	$360K	Sell	3,894 -125	-3%	-$11.3K	0.1%	151
2024 Q3	$337K	Hold	4,019	–	–	0.09%	158
2024 Q2	$276K	Sell	4,019 -500	-11%	-$33.4K	0.08%	169
2024 Q1	$331K	Buy	4,519 +258	+6%	+$19.8K	0.1%	150
2023 Q4	$345K	Hold	4,261	–	–	0.13%	132
2023 Q3	$319K	Hold	4,261	–	–	0.13%	133
2023 Q2	$328K	Buy	4,261 +30	+0.7%	+$2.39K	0.13%	137
2023 Q1	$351K	Sell	4,231 -126	-3%	-$10.4K	0.14%	132
2022 Q4	$374K	Buy	4,357 +126	+3%	+$9.98K	0.15%	128
2022 Q3	$261K	Hold	4,231	–	–	0.11%	151
2022 Q2	$262K	Hold	4,231	–	–	0.11%	154
2022 Q1	$252K	Sell	4,231 -50	-1%	-$3.2K	0.09%	160
2021 Q4	$311K	Buy	+4,281	New	+$295K	0.11%	155

Other funds holding GILD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

High Net Worth Advisory Group's GILD Position: Q2 2026 in Review

High Net Worth Advisory Group held its Gilead Sciences (GILD) position steady in Q2 2026 at 3,786 shares worth $478K. The position accounts for 0.1% of the portfolio, ranked #155.

High Net Worth Advisory Group first reported a position in GILD in Q4 2021 and has held it in 19 quarters since. The position peaked at $528K in Q1 2026. 2,278 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

High Net Worth Advisory Group held 3,786 shares of Gilead Sciences worth $478K as of Q2 2026.
High Net Worth Advisory Group left its Gilead Sciences share count unchanged in Q2 2026.
Gilead Sciences made up 0.1% of High Net Worth Advisory Group's portfolio in Q2 2026, its #155 holding.
High Net Worth Advisory Group first reported a position in Gilead Sciences in Q4 2021 and has held it in 19 quarters since.
High Net Worth Advisory Group's Gilead Sciences position peaked at $528K in Q1 2026.
2,278 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on High Net Worth Advisory Group's 13F filing for Q2 2026, filed 29 Jul 2026.